Streetbeat News

Products Services

META

Threads, a text-based social media platform launched by three former Facebook employees, has a drug content flagging system that warns users about potential harm from substances like marijuana, psychedelics, and fentanyl. However, the system does not provide similar warnings for alcohol and tobacco. The platform has gained popularity with over 10 million downloads, surpassing ChatGPT's record for fastest to one million users.

Portfolio Pulse from Maureen Meehan

July 06, 2023 | 10:03 pm

QTRX

Quanterix has launched LucentAD, a test designed to assist in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer's disease. The test is available through a healthcare provider's order. Lucent Diagnostics plans to announce additional tests for Alzheimer's and other neurological disorders.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 9:39 pm

TSLA

Tesla Inc's energy and solar divisions are allowing users to generate energy that can be sold back to utility companies. In Texas, customers of Tesla Electric have reportedly made up to $150 daily in recent weeks due to rising temperatures. The business is currently only available to Powerwall owners in Texas, with plans to expand in the future. Tesla Energy has passed 500,000 Powerwall installations worldwide.

Portfolio Pulse from Chris Katje

July 06, 2023 | 9:24 pm

BWV

Blue Water Biotech has been granted a license by the Ohio State Board of Pharmacy to operate as a pharmaceutical wholesaler. This is a significant step for the company as it allows patients and providers to access Blue Water products nationwide.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 9:06 pm

ESAIY

The U.S. Food and Drug Administration (FDA) has converted the approval status of Leqembi, a novel Alzheimer's disease treatment, from accelerated to traditional approval. This follows a confirmatory trial that verified the drug's clinical benefit. Leqembi, developed by Eisai Inc., is the first amyloid beta-directed antibody to receive such conversion. The drug reduces amyloid plaques in the brain, a key feature of Alzheimer's disease. The approval was initially granted under the Accelerated Approval pathway, which required a confirmatory study post-approval.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 8:48 pm

BIIB

The FDA has approved Eisai and Biogen's Alzheimer's treatment Leqembi, which is expected to receive broad coverage through Medicare. The treatment, which costs $26,500 per year, slowed cognitive decline in early Alzheimer's patients by 27% over 18 months during Eisai's clinical trial. However, it carries serious risks of brain swelling and bleeding. Medicare plans to impose conditions on how it will cover Leqembi, requiring patients to find a health-care provider participating in a registry system that collects real-world data on the drug's benefits and risks.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 8:47 pm

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) has released its production and operations updates for June 2023. The company mined 460 Bitcoin in June, a 9% increase year-on-year but a 32% decrease from May 2023. Riot also announced an initial order of 33,280 MicroBT miners for its Corsicana Facility, which is expected to add 7.6 EH/s to its self-mining fleet. The company's power strategy, which involves selling power back into the grid during periods of peak demand, generated $8.4 million in power sales and $1.6 million in demand response revenue in June.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 8:46 pm

DIS

The Walt Disney Company (NYSE:DIS) has seen its shares fall in 2023 due to concerns about its box office, streaming platform, and advertising revenue. Despite having several high-grossing films, Disney's movies are underperforming compared to previous years. The company's chances of reaching the $1 billion milestone at the worldwide box office in 2023 appear slim. However, Disney's consumer products business remains successful and helps cushion the blow of movies not doing as well in theaters.

Portfolio Pulse from Chris Katje

July 06, 2023 | 8:45 pm

CWBHF

CWEB

The New York Media Softball League (NYMSL) has secured a sponsorship with Cornbread Hemp, a Kentucky-based CBD company. This marks the first collaboration between a CBD company and a non-professional league. As part of the sponsorship, players will receive custom hats with Cornbread Hemp's logo and samples of their CBD products. The partnership highlights the increasing acceptance of cannabis-related products within the sports industry.

Portfolio Pulse from Joana Scopel

July 06, 2023 | 8:22 pm

ESEA

Euroseas Ltd. (NASDAQ:ESEA) has taken delivery of its M/V Terataki, a 2,800 teu feeder containership newbuilding from Hyundai Mipo Dockyard Co. The vessel, equipped with a Tier III engine and other sustainability features, was financed with a combination of own funds and a sustainability-linked loan from National Bank of Greece S.A. The vessel has commenced a 36 to 40 months charter with Asyad Lines. The company expects the charter to contribute over $42 million of EBITDA to the company.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 8:08 pm